Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland.
School of Medicine, Dentistry and Biomedical Sciences, Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Ophthalmol Glaucoma. 2021 Sep-Oct;4(5):454-462. doi: 10.1016/j.ogla.2021.01.007. Epub 2021 Feb 9.
To identify systematic reviews of interventions for glaucoma conditions and to assess their reliability, thereby generating a list of potentially reliable reviews for updating glaucoma practice guidelines.
Cross-sectional study.
Systematic reviews of interventions for glaucoma conditions.
We used a database of systematic reviews and meta-analyses in vision research and eye care maintained by the Cochrane Eyes and Vision United States Satellite. We examined all Cochrane systematic reviews of interventions for glaucoma conditions published before August 7, 2019, and all non-Cochrane systematic reviews of interventions for glaucoma conditions published between January 1, 2014, and August 7, 2019.
We assessed eligible reviews for reliability, extracted characteristics, and summarized key findings from reviews classified as reliable.
Of the 4451 systematic reviews in eyes and vision identified, 129 met our eligibility criteria and were assessed for reliability. Of these, we classified 49 (38%) as reliable. We found open-angle glaucoma (22/49) to be the condition with the most reviews and medical management (17/49) and intraocular pressure (IOP; 43/49) to be the most common interventions and outcomes studied. Most reviews found a high degree of uncertainty in the evidence, which hinders the possibility of making strong recommendations in guidelines. These reviews found high-certainty evidence about a few topics: reducing IOP helps to prevent glaucoma and its progression, prostaglandin analogs are the most effective medical treatment for lowering IOP, laser trabeculoplasty is as effective as medical treatment as a first-line therapy in controlling IOP, the use of IOP-lowering medications in the perioperative or postoperative periods to accompany laser (e.g., trabeculoplasty) reduces the risk of postoperative IOP spikes, conventional surgery (i.e., trabeculectomy) is more effective than medications in reducing IOP, and antimetabolites and β-radiation improve IOP control after trabeculectomy. The evidence is weak regarding the effectiveness of minimally invasive glaucoma surgeries.
Most systematic reviews evaluating interventions for glaucoma are of poor reliability. Even among those that may be considered reliable, important limitations exist in the value of information because of the uncertainty of the evidence as well as small and sometimes unimportant clinical differences between interventions.
确定治疗青光眼的干预措施的系统评价,并评估其可靠性,从而为更新青光眼实践指南生成一份潜在可靠的评价列表。
横断面研究。
治疗青光眼的干预措施的系统评价。
我们使用由考科蓝眼科和视力美国分部维护的视光学和眼保健系统评价和荟萃分析数据库。我们查阅了 2019 年 8 月 7 日前发表的所有治疗青光眼的考科蓝系统评价和 2014 年 1 月 1 日至 2019 年 8 月 7 日发表的所有治疗青光眼的非考科蓝系统评价。
我们评估了纳入研究的可靠性,提取了特征,并总结了被归类为可靠的评价的关键发现。
在已确定的 4451 篇眼部和视觉系统评价中,有 129 篇符合纳入标准并进行了可靠性评估。其中,我们将 49 篇(38%)归类为可靠。我们发现开角型青光眼(22/49)是研究最多的疾病,而药物治疗(17/49)和眼内压(IOP;43/49)是最常见的干预措施和研究结果。大多数评价发现证据存在高度不确定性,这阻碍了在指南中做出强有力推荐的可能性。这些评价发现了一些主题的高确定性证据:降低 IOP 有助于预防青光眼及其进展,前列腺素类似物是降低 IOP 最有效的药物治疗方法,激光小梁成形术作为一线治疗方法在控制 IOP 方面与药物治疗同样有效,在激光(如小梁成形术)围手术期或术后使用降眼压药物可降低术后 IOP 飙升的风险,传统手术(即小梁切除术)比药物治疗更有效地降低 IOP,抗代谢物和β射线可改善小梁切除术治疗后的眼压控制。微创青光眼手术的有效性证据较弱。
评估青光眼治疗干预措施的大多数系统评价可靠性差。即使在那些可能被认为是可靠的评价中,由于证据的不确定性以及干预措施之间的临床差异较小且有时并不重要,信息的价值也存在重要的局限性。